These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32463443)

  • 1. Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life.
    Buchwald AG; Graham BS; Traore A; Haidara FC; Chen M; Morabito K; Lin BC; Sow SO; Levine MM; Pasetti MF; Tapia MD
    Clin Infect Dis; 2021 Dec; 73(11):e4421-e4427. PubMed ID: 32463443
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
    Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
    J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Syncytial Virus (RSV)-Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants.
    Koivisto K; Nieminen T; Mejias A; Capella Gonzalez C; Ye F; Mertz S; Peeples M; Ramilo O; Saxén H
    J Infect Dis; 2022 Apr; 225(7):1189-1196. PubMed ID: 34129040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
    Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Atwell JE; Thumar B; Formica MA; Robinson LJ; Walsh EE; King CL; Karron RA
    Pediatr Infect Dis J; 2019 Sep; 38(9):e199-e202. PubMed ID: 31408055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.
    Chu HY; Steinhoff MC; Magaret A; Zaman K; Roy E; Langdon G; Formica MA; Walsh EE; Englund JA
    J Infect Dis; 2014 Nov; 210(10):1582-9. PubMed ID: 24903663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants.
    Suryadevara M
    J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S110-S114. PubMed ID: 38995085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.
    Jones BG; Sealy RE; Surman SL; Portner A; Russell CJ; Slobod KS; Dormitzer PR; DeVincenzo J; Hurwitz JL
    Vaccine; 2014 May; 32(26):3264-73. PubMed ID: 24721531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.
    Nyiro JU; Sande CJ; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    PLoS One; 2016; 11(11):e0166706. PubMed ID: 27851799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
    Liang B; Matsuoka Y; Le Nouën C; Liu X; Herbert R; Swerczek J; Santos C; Paneru M; Collins PL; Buchholz UJ; Munir S
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection.
    Taleb SA; Al-Ansari K; Nasrallah GK; Elrayess MA; Al-Thani AA; Derrien-Colemyn A; Ruckwardt TJ; Graham BS; Yassine HM
    Int J Infect Dis; 2021 Aug; 109():56-62. PubMed ID: 34118428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.
    Patel SM; Jallow S; Boiditswe S; Madhi SA; Feemster KA; Steenhoff AP; Arscott-Mills T; Muthoga C; Ajibola G; Shapiro R; Shah SS; Cunningham CK; Kelly MS
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):349-356. PubMed ID: 31549157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.
    Nyiro JU; Sande C; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    Vaccine; 2015 Apr; 33(15):1797-801. PubMed ID: 25725445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
    Welliver RC; Papin JF; Preno A; Ivanov V; Tian JH; Lu H; Guebre-Xabier M; Flyer D; Massare MJ; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2020 Jan; 38(5):1258-1270. PubMed ID: 31761502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    Buchholz UJ; Cunningham CK; Muresan P; Gnanashanmugam D; Sato P; Siberry GK; Rexroad V; Valentine M; Perlowski C; Schappell E; Thumar B; Luongo C; Barr E; Aziz M; Yogev R; Spector SA; Collins PL; McFarland EJ; Karron RA;
    J Infect Dis; 2018 Apr; 217(9):1338-1346. PubMed ID: 29509929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental Respiratory Syncytial Virus and Influenza Virus Antibody Transfer in Alaska Native and Seattle Mother-Infant Pairs.
    Chu HY; Newman KL; Englund JA; Cho S; Bull C; Lacombe K; Carlin K; Bulkow LR; Rudolph K; DeByle C; Berner J; Klejka J; Singleton R
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):230-236. PubMed ID: 32369172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort.
    Yildiz M; Kara M; Sutcu M; Mese S; Demircili ME; Sivrikoz TS; Torun SH; Agacfidan A; Coban A; Unuvar E; Somer A
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1279-1286. PubMed ID: 32060753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.